Recently, dual sEH/AchE inhibitors have been synthesized for targeting Alzheimer’s disease by linking 6-chlorotacrine or huperine Y, a chiral derivative of tacrine, to the propanoyl group of TPPU [104]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.